• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
50,952.25 25.20
(0.05%)
Dow Jones
7,687.74 15.20
(0.20%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
95.92 -0.05
(-0.05%)
EUR-INR
108.79 -0.10
(-0.09%)
GBP-INR
127.19 0.21
(0.17%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter
May 15,2026
Net profit of Solara Active Pharma Sciences reported to Rs 9.60 crore in the quarter ended March 2026 as against net loss of Rs 2.10 crore during the previous quarter ended March 2025. Sales rose 41.86% to Rs 387.29 crore in the quarter ended March 2026 as against Rs 273.01 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 7.41 crore in the year ended March 2026 as against net profit of Rs 0.54 crore during the previous year ended March 2025. Sales rose 6.64% to Rs 1368.98 crore in the year ended March 2026 as against Rs 1283.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales387.29273.01 42 1368.981283.76 7
OPM %14.8916.62 -13.6416.07 -
PBDT34.7822.20 57 98.1699.79 -2
PBT8.74-2.10 LP -1.520.54 PL
NP9.60-2.10 LP -7.410.54 PL